The JNC-7 classification includes normal BP, prehypertension, stage 1 hypertension, and stage 2 hypertension.
|
|
- Irene Owen
- 6 years ago
- Views:
Transcription
1 Hypertension is defined as an elevated SBP ( 140 mm Hg), DBP ( 90 mm Hg), or both. - A clinical diagnosis of hypertension is based on the mean of two or more properly measured seated BP measurements taken on two or more occasions. - This mean BP is also used to initially classify and stage hypertension. The JNC-7 classification includes normal BP, prehypertension, stage 1 hypertension, and stage 2 hypertension. Classification SBP mmhg DBP mmhg Normal <120 and <80 Prehypertension or Stage 1 hypertension or Stage 2 hypertension 160 or 100 Aetiology: Hypertension is the most common cardiovascular disorder. 1. Primary (or essential) hypertension, constitutes 90-95% of all cases of systemic hypertension. - The average age of onset is about 35 years. - The precise aetiology of essential hypertension is currently unknown, - Genetic factors clearly play a part as the condition clusters in families, with hypertension being twice as common in subjects who have a hypertensive parent. 2. Secondary hypertension, accounts for the remaining 5-10% of cases of systemic hypertension. - This type usually develops between the ages of 30 and There are specific identified causes for the elevated BP & these includes: Renal diseases Endocrine diseases Steroid excess: hyperaldosteronism (Conn's syndrome) Hyperglucocorticoidism (Cushing's syndrome) Growth hormone excess: acromegaly 1
2 Catecholamine excess: phaeochromocytoma Others: pre-eclampsia Vascular causes Renal artery stenosis: fibromuscular hyperplasia; Renal artery atheroma; coarctation of the aorta Drugs Sympathomimetic amines Oestrogens (e.g. combined oral contraceptive pills) Ciclosporin Erythropoietin NSAIDs Steroids White-coat hypertension, refers to patients without target-organ disease who have consistently elevated BP values measured in a clinical environment (e.g., physician's office) that are significantly higher than those obtained by either a manual reading outside this environment (e.g., home) or with 24-hour ambulatory monitoring. - Patients with white-coat hypertension are at risk for developing hypertension - Patients with white-coat hypertension are at a higher risk for cardiovascular disease than normotensive patients. Hypertensive crises, is situations which arise when measured BP values are excessively high (> 180/110 mm Hg). It's further classified to: a) Hypertensive emergency (with acute or chronic end-organ damage), it require hospitalization for immediate BP lowering using IV medications. b) Hypertensive urgency (without acute end-organ damage). This does not require immediate BP lowering; instead, BP should be slowly reduced within 24 hours. Isolated systolic hypertension (ISH), is defined as an elevated SBP (>140 mm Hg) with a normal DBP (< 90 mm Hg). This pattern of hypertension is most common in patients older than 65 yrs. 2
3 Regulation of blood pressure BP is normally regulated by compensatory mechanisms that respond to changes in cardiac demand. MAP = CO x TPR an increase in cardiac output (CO) normally results in a compensatory decrease in total peripheral resistance (TPR). an increase in TPR results in a decrease in CO. Adverse changes in BP can occur when these compensatory mechanisms are not functioning properly. It has been suggested that in hypertension an initial increase in fluid volume increases CO and arterial pressure. Eventually, with long-standing hypertension, it is believed that TPR increases so that CO returns to normal. 1- Sympathetic nervous system (controls α- and ß-receptors), which causes contraction and relaxation of vascular smooth muscle. Stimulation of α-adrenergic receptors in the central nervous system (CNS) results in a reflex decrease in sympathetic outflow causing a decrease in BP. Stimulation of postsynaptic α1-receptors in the periphery causes vasoconstriction. Stimulation of postsynaptic ß1-receptors (myocardium) causes an increase in heart rate and contractility. Stimulation of postsynaptic ß2-receptors in the arterioles and venules results in vasodilation. 2- Renal function and renal blood flow (influences fluid and electrolyte balance) Increased fluid volume increases venous system distention and venous return, affecting cardiac output and tissue perfusion. These changes alter vascular resistance, increasing the blood pressure. 3
4 3- The renin-angiotensin-aldosterone system (RAAS) Angiotensin-II has several important functions in the regulation of fluid volume: a. it stimulates the release of aldosterone from adrenal gland, which results in increased sodium reabsorption, fluid volume, and blood pressure. b. It constricts resistance vessels, which increases peripheral vascular resistance and arterial pressure. c. It stimulates the release of vasopressin, or antidiuretic hormone (ADH), from the posterior pituitary, which acts within the kidneys to increase fluid retention. d. It stimulates cardiac hypertrophy and vascular hypertrophy e. It facilitates norepinephrine release from sympathetic nerve endings and inhibits norepinephrine reuptake by nerve endings, which enhances sympathetic function. 4. Electrolytes & hypertension 1) Sodium: patients with high dietary sodium intake has a greater prevalence of hypertension than those with a low sodium intake. The mechanism by which hypertension is caused by an increase in sodium intake is hypothesized to involve natriuretic hormone. Natriuretic hormone might cause an increase in intracellular sodium and calcium, resulting in increased vascular tone and hypertension. 2) Calcium Epidemiologic evidence and clinical trials have demonstrated an inverse relationship between calcium and BP. 4
5 One proposed mechanism for this relationship involves an alteration in the balance between intracellular and extracellular calcium. Increased intracellular calcium concentrations can increase peripheral vascular resistance, resulting in increased BP. 3) Potassium, a decrease in potassium has been associated with an increase in peripheral vascular resistance. It is important that potassium concentrations be maintained within the normal range because hypokalemia increases the risk of cardiovascular events, such as sudden death. 5- Mosaic theory centers around the fact that multiple factors, rather than one factor alone, are responsible for sustaining hypertension. The interactions among the sympathetic nervous system, RAA system & potential defects in sodium transport within and outside the cell may all play a role in long-term hypertension. Other vasoactive substances that are involved in the maintenance of normal blood pressure include: - Nitric oxide (potent vasodilatling factor): is produced in the endothelium. Hypothetically, hypertensive patients could have an intrinsic deficiency in NO release and inadequate vasodilation, which may contribute to hypertension and/or its vascular complications. - Endothelin (vasoconstrictor peptide). - bradykinin (potent vasodilator inactivated by ACE), - Atrial natriuretic peptide (naturally occurring diuretic). Hypertension-related target organ damage and major cardiovascular risk The relationship between elevated blood pressure and CVD was addressed in the JNC-7, which formalizes the fact that the higher the blood pressure, the greater the chance of a myocardial infarction (Ml), heart failure (HF), stroke, or kidney disease. Beginning at a benchmark BP of 115/75 mm Hg, the risk of cardiovascular disease doubles with every increment of 20/10 mm Hg. Clinically, it is important to note that having elevated SBP ( 140 mm Hg) is a more reliable predictor of cardiovascular disease than elevated DBP in people older than 50 years of age (Therefore, SBP is the primary target of evaluation and intervention for most patients). 5
6 Target organ damage 1. Heart - Indirect effects: by proving atherosclerotic changes (modest elevation of blood pressure) - Direct effects: via pressure related effects (blood pressure is greatly rising). Hypertension can promote CVD and increase risk for ischemic events, such as angina and Ml, LVH, HF, and arrhythmias 2. Brain Transient ischemic attacks, ischemic strokes, multiple cerebral attacks and hemorrhages. A sudden, prolonged increase in systolic BP also can cause hypertensive encephalopathy (hypertensive emergency). 3. Kidney o Decrease GFR o Decreased blood flow leads to an increase in RA secretion, which heightens the reabsorption of sodium and water and increases blood volume. o Accelerated atherosclerosis decreases the oxygen supply, leading to renal parenchymal damage with decreased filtration capability and to azoternia. The atherosclerosis also decreases blood flow to the renal arterioles, leading to nephrosclerosis and, ultimately, renal failure (acute as well as chronic). o chronic renal disease, whether mild or severe, can progresses to failure o Polyuria, nocturia, and diminished ability to concentrate urine; protein and red blood cells in urine; elevated serum creatinine 4. Peripheral arterial disease Atherosclerotic vascular disease. Absence of pulses in extremities with or without intermittent claudication; development of aneurysm. 5. Eye Hypertension causes retinopathies that may progress to blindness. Retinopathy is evaluated according to the Keith, Wagener, and Barker funduscopic classification system. Grade 1: narrowing of the arterial diameter, indicating vasoconstriction. 6
7 Grade 2: Arteriovenous (AV) nicking indicating atherosclerosis Grade 3: cotton wool exudates and flame haemorrhages (Longstanding untreated hypertension or accelerated hypertension) Grade 4: papilledema (severe cases) Sign and symptoms Hypertension is usually asymptomatic until complications develop in target organs. Dizziness, flushed face, headache, fatigue, epistaxis, and nervousness are not caused by uncomplicated hypertension. Malignant (accelerated) hypertension, is an uncommon condition characterised by greatly elevated blood pressure (usually >220/120 mmhg) associated with evidence of ongoing small vessel damage. - Fundoscopy may reveal papilloedema, haemorrhages and/or exudates, - renal damage can manifest as haematuria, proteinuria and impaired renal function. - The condition may be associated with hypertensive encephalopathy, which is caused by small vessel changes in the cerebral circulation associated with cerebral oedema. The clinical features are confusion, headache, visual loss, seizures and coma. - Brain imaging (particularly MRI) usually demonstrates extensive white matter changes. - it is a medical emergency that requires hospital admission and rapid control of blood pressure over h towards normal levels. Diagnosis Hypertension is diagnosed and classified by: 1. Sphygmomanometery: BP must be measured twice first with the patient supine or seated, then after the patient has been standing for 2 min on 3 separate days. - The average of these measurements is used for diagnosis. - Ideally, BP is measured after the patient rests > 5 min and at different times of day. 2. History: The history includes the known duration of hypertension and previously recorded levels; any history or symptoms of CAD, HF, or other relevant coexisting disorders (eg, stroke, renal dysfunction, peripheral arterial disease, dyslipidemia, diabetes, gout); and a family 7
8 history of any of these disorders. Social history includes exercise levels and use of tobacco, alcohol, and stimulant drugs (prescribed and illicit). A dietary history focuses on intake of salt and stimulants (eg, tea, coffee, caffeine-containing sodas, energy drinks). 3. Physical examination: The physical examination includes measurement of height, weight, and waist circumference; funduscopic examination for retinopathy; and a full cardiac, respiratory, and neurologic examination. The abdomen is palpated for kidney enlargement and abdominal masses. Peripheral arterial pulses are evaluated. 4. Testing: The more severe the hypertension and the younger the patient, the more extensive is the evaluation. Generally, when hypertension is newly diagnosed, routine testing to detect target-organ damage and cardiovascular risk factors is done. Tests include: Multiple measurements of BP to confirm Urinalysis & urinary albumin:creatinine ratio; if abnormal, consider renal ultrasonography Blood tests: Fasting lipids, creatinine, K If creatinine increased, renal ultrasonography If K decreased, evaluate for aldosteronism ECG: If left ventricular hypertrophy, consider echocardiography Sometimes thyroid-stimulating hormone measurement If BP elevation is sudden and labile or severe, evaluate for pheochromocytoma Assessment of hypertensive patients First: the presence and absence of various forms of hypertension-related target organ damage should be assessed. Second: secondary causes of hypertension, if present, should be identified and managed accordingly. Third: major risk factors, concomitant disorders, and lifestyle habits should be evaluated so that they can be used to guide therapy and influence prognosis. 8
9 Target blood pressure Most patients with hypertension have a BP goal of < 140/90 mm Hg. The BP goal is < 130/80 mm Hg for patients with diabetes or chronic kidney disease, because they are at very high risk for target-organ damage. Goals of Therapy The ultimate goal of therapy is to lower hypertension-related morbidity and mortality. a- Lifestyle Modifications 1. Weight reduction (Maintain normal body weight BMI =18.5 to 24.9 kg/m 2 ) 2. Adopt DASH eating plan (Consume a diet rich in fruits, vegetables, and low-fat dairy products with a reduced content of saturated and total fat) 3. Dietary sodium restriction (Reduce daily dietary sodium intake to 100 meq (2.4 g sodium or 6 g sodium chloride) 4. Physical activity (Engage in regular aerobic physical activity at least 30 min/day, most days of the week) 5. Moderate alcohol consumption 6. Smoking cessation: Smoking result in vasoconstriction and activation of the SNS & is a major risk factor for cardiovascular disease. b- Starting Drug Therapy Stepped care approach, the stepped-care approach has traditionally been used when initiating therapy. - A single agent is selected with the dose increased until BP is controlled, the maximum dose is reached, or dose-limiting toxicity occurs. - If the goal BP is not achieved, a second drug from a different class is added. - Theoretically, this process can be continued, if necessary, until three or even four drugs are used in combination. Sequential therapy, the sequential therapy approach is similar to the stepped care approach in that an agent is started and titrated to the maximum dose as needed. - If goal BP is not achieved, an alternative agent is selected to replace the first. - Combination drug therapy is reserved for patients who do not achieve goal BP values after the second agent. 9
10 - Sequential therapy seems most appropriate when the first drug is either poorly tolerated or results in minimal or no reduction in BP. Combination Therapy Starting therapy with a combination of two drugs is now strongly encouraged for certain patients. This approach is recommended for all patients with stage 2 hypertension or those who are far from their goal (e.g., 20 mm Hg from SBP goal or 10 mm Hg from DBP goal, according to JNC 7). Initial combination therapy is also an option for patients in whom goal achievement may be difficult (i.e., diabetes, chronic kidney disease, African Americans) or in complex patients in whom there are multiple compelling indications for different antihypertensive agents. Stepped -Down Therapy A small number of patients with long-standing hypertension can later have their BP medications slowly withdrawn, resulting in normal BP values for weeks or months following discontinuation of their medications. This is called step-down therapy. Step-down therapy: This consists of attempting to decrease the dosage and/or number of antihypertensive drugs without compromising BP control. Step-down therapy is most often successful in patients who have lost significant amounts of weight or have drastically changed their lifestyle. Antihypertensive agents 1. Diuretics When initially started, they induce a natriuresis that decreases plasma volume so cause a decrease in CO (Diuresis usually depresses after chronic use with some of these agents, especially with thiazide diuretics). However, the long-term BP lowering effects are maintained because of a sustained decrease in peripheral vascular resistance (PVR). Diuretics are commonly prescribed as the initial antihypertensive drug because: - They are cheap - Have low incidence of side effect - High level of efficacy - High patients acceptability 10
11 - They reduce morbidity and mortality rates. - Diuretics are generally well tolerated, and most can be given once daily. But the biochemical alteration IS a problem and this can be decreased by using a small dose Types of diuretics: 1. Thiazides and related diuretics Thiazide-type diuretics are the diuretics of choice for hypertension. Goal BP values <140/90 mm Hg are achieved in 45% to 80% of patients who take these drugs. They differ primarily in the duration of action: < 12 hr......chlorthiazides, hydrochlorothiazide, hydroflomethiazide Up to 24 hr.....bendroflumethiazide, benzthiazide, metalazone, > 12 hrchlorthalidone, polythiazide, cyclothiazide Properties - Moderately potent diuretic - Act within 1-2 hr after oral administration - Administration should be early in the day (diuresis will not interfere with patients sleep) Use and choice They are all similar in effect but differ in the cost Effective in black patients (HTN is often volume dependent) Effective in elderly: because of freedom from acute toxicity in low dose They should not be used in HTN patient with renal failure (creatine clearance< 30) Side effects - Decrease Na, Mg, K and hypovolemia o hyperuricemia, hypercholestrolemia, hypertriglyceridemia, hyperglycemia & hypecalcaemia - Sexual dysfunction - Weakness, muscle cramps, GI disturbance. - Skin rash - Patients with known allergies to sulfa-type drugs should be questioned to determine the significance of the allergy. Significant interaction - NSAIDs, such as ibuprofen, interact to diminish the antihypertensive effects of the thiazide diuretics. 2. Loop diuretics - Produce a more potent diuresis, a smaller decrease in PVR, and less vasodilation than thiazide-type diuretics. - Their action is more intense but of shorter duration (1-4 hr) than that of the thiazides; they may also be more expensive. 11
12 Note/ hydrochlorothiazide is more effective than loop diuretic in lowering B.P in most patients (V.D + longer duration in addition to Na & water) Uses Pulmonary edema due to left ventricular failure CHF Renal failure (creatine clearance < 30 ml/min) Examples Furosemide (lasix), Bumetanide, Torasemide & Ethacrynic acid Furosemide & Bumetanide, are similar in activity after oral administration the onset is 1 hr and duration= 6 hr so given twice or once daily without interferences with patients sleep - I.V administration peak after 30 min. Side effect Similar to thiazides but they cause hypocalcaemia Toxicity/ fuorosemide cause deafness Bumetanide cause mylagia Significant interaction - As with the thiazides, the antihypertensive effect of loop diuretics may be diminished by NSAIDs. - Aminoglycoside. ototoxicity. - Digitalis... digitalis toxicity 3. K sparing diuretics (amiloride + triamterine) They are used for patients who develop hypokalemia while taking diuretics They are weak diuretics when used alone They cause retention of K therefore used as a more effective alternative to giving K supplementation with thiazide or loop diuretic. These agents are often used in combination with a thiazide diuretic e.g: (thiazide + amiloride = Moduretic) because they potentiate the effects of the thiazide while minimizing potassium loss. Aldosterone antagonists (spironolactone and eplerenone) They are also classified as potassium sparing diuretics. Blocking of the aldosterone receptor inhibits Na & water retention, and inhibits vasoconstriction. Hyperkalemia is a known dose-dependent effect with these agents that is more prominent in patients with chronic kidney disease and with eplerenone (compared with spironolactone) because eplerenone is a more specific aldosterone blocker. Spironolactone is particularly useful in patients with hyperaldosteronism, as it has direct antagonistic effects on aldosterone. Gynecomastia is a side effect of spironolactone that does not occur with eplerenone. These agents are indicated for hypertension, but their greatest use may be in HF because of evidence showing reduced morbidity and mortality. 12
13 Significant interaction Coadministration with ACE inhibitors, Ag II antagonist or potassium supplements significantly increases the risk of hyperkalemia. Precautions and monitoring effect - Potassium-sparing diuretics should be avoided in patients with acute renal failure and used with caution in patients with impaired renal function (monitor serum creatinine) because they can retain potassium. Side effects Hyperkalemia, GI disturbances, gynecomastia, haisutism and menstrual irregularity Diuretic induced hypokalemia The incidence occurs in 14-60% of patients and is dose dependent and this can be managed by: 1- decreasing the dose 2- K-rich food: dried fruit, bananas & orange juice 3- K-sparing diuretic 4- K-supplementation (oral KCl tablet &syrup, Potassium bicarbonate, gluconate, acetate and citrate salts) This management is needed in; 1- patients on digoxin 2- high dose corticosteroid 3- hyperaldosteronism 4- Cirrhosis, D.M, chronic diarrhea, starvation, MI & angina. Other indications for diuretics Thiazide diuretics decrease urinary calcium excretion and have been used to prevent stone formation in patients with calcium-related kidney stones (The resulting elevations in serum calcium concentrations are usually asymptomatic and of little clinical significance, but may be beneficial in postmenopausal patients or in patients with osteoporosis). Contrary to thiazide-type diuretics, loop diuretics increase renal clearance of calcium and have been used for acute management of severe hypercalcemia. 13
14 2. ß- Blockers ß- Blockers have several direct effects on the cardiovascular system: - decrease cardiac contractility and output, - lower heart rate, - blunt sympathetic reflex with exercise, - reduce central release of adrenergic substances, - inhibit norepinephrine release peripherally, - decrease renin release from the kidney. All ß-blockers have similar activity with regard to BP lowering, and patients whose conditions fail to respond to one generally fail to respond to others. Pharmacologic difference Clinically important differences relate primarily to cardioselectivity, intrinsic sympathomimetic activity (ISA) and relative lipid solubility. 1. CARDIOSELECTIVITY (atenolol, acebutolol, bisoprolol, metoprolol, betaxolol) o Some ß-blockers demonstrate relative cardioselectivity with greater antagonism of cardiac β1-receptors and less activity on ß2-receptors in the lung or bronchial tissue. However, selectivity is not absolute since it is dose-dependent (asthma has been precipitated even with cardioselective agents when they are used in higher doses, but not with low to moderate doses). Therefore, no ß -blocker is totally safe in patients with bronchospastic disease for example asthma and COPD. o Nonselective ß-blockers potentially have the disadvantage of blunting the symptoms of hypoglycemia in patients with type I diabetes. o β2-blockade from nonselective ß-blockers can lead to unopposed α-induced peripheral vasoconstriction. This may worsen Raynaud's phenomenon, peripheral arterial disease, or hypertension caused by catecholamine-producing tumors (pheochromocytoma). o Nonselective ß-blockers are preferred in patients with noncardiovascular indications for ß -blocker therapy such as migraine prophylaxis or essential tremor. 14
15 2. INTRINSIC SYMPATHOMIMETIC ACTIVITY (acebutolol, carteolol, penbutolol, and pindolol) ISA represent the capacity of ß-blocker to stimulate as well as to block adrenergic receptors. β-blockers with ISA partially stimulate ß-receptors while attached to this receptor, but much less than a pure agonist. When given to a patient with a slow resting heart rate, they can increase the heart rate. Conversely, these agents can slow heart rate in patients with resting or exercise induced tachycardia, because β-blocking properties predominate. They are theoretically less likely to cause bradycardia, bronchospasm, reduced cardiac output, peripheral vasoconstriction, and increased plasma lipids than non-selective ßblockers. These agents still might worsen asthma or exacerbate HF or angina in patients with CAD. They should never be used in patients with a history of MI because they may have detrimental effects as a result of their agonist properties. They should be avoided in patients who have contraindications to or adverse reactions with non-isa ß-blockers. Perhaps the only role for ISA ß-blockers is in patients who require a ß-blocker, but experience severe bradycardia from non-isa agents. Pindolol has the greatest ISA. Celiprolol combine selective ß1-blocker + selective β2 stimulant activity which also counteract P-vasoconstriction. 3. LIPID SOLUBILITY Lipophilic ß-blockers (e.g penbutolol & carvidolol & propranolol) have a larger volume of distribution and undergo more extensive first-pass hepatic metabolism than hydrophilic ß- blockers (e.g atenolol, nadolol, sotalol). Highly lipcphilic agents theoretically penetrate the CNS more extensively and readily than hydrophilic ß-blockers therefore: - They are preferable for migraine prophylaxis. - They are associated with increased CNS side effects such as drowsiness, mental confusion, nightmares, or depression. Considering lipid solubility is most clinically relevant when selecting a ß-blocker for a patient with renal or hepatic impairment. 15
16 Highly hydrophilic ß-blockers (e.g., atenolol) are primarily excreted by the kidneys and may require lower doses in patients with moderate to severe chronic kidney disease. High lipid soluble drugs are hepatically cleared. Side effects & contraindications of β-blockers: Site Side effect Caution & contraindication Bronchial smooth muscle Bronchoconstriction COPD & asthma P- arterioles v-constriction, cold extremities, muscle weakness, fatigue PVD, Raynaud's syndrome Myocardium Fatigue, decrease exercise Caution in HF, -negative inotropic tolerance, bradycardia C.In in heart block, -negative chronotropic bradycardia Systemic ß receptors Atherogenic dyslipidemia, Care in dyslipidemia response to hypoglycemia Pancrease insulin secretion (herperglycemia) Type II DM CNS & others Night mares, confusion, Avoid evening dose and depression, psychotic reaction, lipophilic agents Impotence Note/ Nonselective ß-blockers have been associated with increased serum triglycerides and reductions in HDL cholesterol. Agents with ISA have little or no effects on lipids, whereas cardioselective ß-blockers have intermediate effects. Why should a β-blocker never be abruptly discontinued? Chronic ß-blocker therapy up regulates the expression of ß-receptors. However, this does not result in rise of BP while ß-blocker therapy is maintained to occupy the receptors. If ß- blocker therapy is abruptly stopped more ß-receptors are available to be activated, causing cardiac stimulation and vasoconstriction & this will cause: - Rebound hypertension: headache, tachycardia, and possibly anxiety. - Patients with ischemic heart disease can have significant increases in angina frequency if ß-blockers are abruptly stopped. 16
17 Therefore ß-blockers should be discontinued by gradually tapering the dose by 50% for 3 days and then another 50% for 3 days. Replacing one ß-blocker with another should not cause rebound hypertension. 3. Angiotensin-Converting Enzyme Inhibitors (captopril, enalapril, benzapril, lisinopril, ramipril). - ACE-inhibitors has a direct local effect on arteriole of systemic and renal vasculature. - ACE inhibitors are believed to provide unique cardiovascular benefits by improving endothelial function, promoting LVH regression and collateral vessel development, and improving insulin sensitivity. Notes The effect or response of ACE-I become more pronounced with time, response at 3 months >> than seen at 2-4 weeks. This delay may be related to the diuretic effect + slow reversal of V-constrictor effect of Ag II, catecholamine & vasopressin. Because there are additional pathways for the formation of angiotensin II, ACE inhibitors do not completely block the production of angiotensin II. Bradykinin accumulates in some patients may lead to additive vasodilation by releasing nitrous oxide; bradykinin can also cause a dry cough in some patients. ACE inhibitor monotherapy is more effective at lowering BP in young white patients than in African American or elderly patients (they have low renin hypertension). 17
18 Pharmacological Considerations. Some of these agents are primarily renally eliminated (benazepril, enalapril, lisinopril, quinapril, ramipril), and others have mixed hepatic and renal elimination (captopril, fosinopril, perindopril, trandolapril). Moexipril is the only ACE inhibitor that is almost completely hepaticaily eliminated. All ACE-inhibitors are equally effective, but they differ in: (Potency, pharmacokinetic properties, duration of action, adverse effect & clinical indications) All of them (except captopril) must be hepatically converted to active substance e.g (enalpril is hydrolyzed to enaliprilate) so there is delay in onset of action, (but not with chronic therapy) Newer agents have a slow rate of elimination & long duration of action. They are associated with fewer incidence of side effects such as rash, taste disturbance (agensia) and this may be related to the fact that captopril has a sulfhydryl group on its molecule while other ACE-I don't. This SH group is associated with high incidence of rash, agensia, proteinuria & neutropenia. Side effects Hypotension..Common especially 1st dose effect Renal impairment..renal insufficiency can occur in patients with predisposing factors, such as renal stenosis, and when ACE inhibitors are administered with thiazide diuretics, HF or patients on NSAID. Hyperkalemia.Avoid K-sparing diuretics, K-supplementation & NSAID. Dry cough..if persist change to Ag receptor blocker. Angioedema.rare (kinin related) Neutropenia, agranulocytosis (bone marrow toxicity) rare. Proteinurea, agensia, skin rash.rare, only captopril in high doses. Risk of hypotension Patients who are either volume depleted, hyponatremic, or have an exacerbation of HF, very elderly, or frail may experience a significant first-dose response to an ACE inhibitor. This can manifest as orthostatic hypotension, dizziness, or possibly syncope (These patients should initiate ACE inhibitor therapy at half the normal dose). Concurrent diuretic therapy may predispose some patients to first-dose hypotension. When ACE inhibitors were first approved, dosing guidelines recommended starting at half the 18
19 standard dose of the ACE inhibitor, decreasing the dose of the diuretic, or stopping the diuretic before initiating the ACE inhibitor. Other considerations ACE inhibitors are teratogenic in the second and third trimester. Their use in women of child bearing age is discouraged. If used in this population, patient education should be explicitly clear regarding risks to the fetus which include potentially fatal hypotension, anuria, renal failure, and developmental deformities (A highly effective form of contraception should be strongly recommended). Indications - Useful in diabetic nephropathy because they diminish proteinurea and stabilize renal function (delay in progression of nephropathy) - Are effective in patients with hypertension related to renal artery disease, however caution must be taken when use ACE-I in patients with bilateral renal artery stenosis or who have stenosis in a solitary kidney following nephroctomy. - They are more effective in young, white patients because elderly, black have low rennin activity but may respond to ACE-I. - Following myocardial infarction, they have a direct tissue effect since the wall of artery or myocardium contain RAAS so ACE-I prevent morphologic changes (remodeling) following MI or otherwise lead to CHF. - Decrease morbidity & mortality in CHF & left ventricular dysfunction. Significant interaction The antihypertensive effect of ACE inhibitors may be diminished by NSAIDs (e.g., OTC forms of ibuprofen). 4. Angiotensin II receptor blockers (candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan and valsartan). They directly block the angiotensin II type 1 receptor site. Therefore, they block angiotensin II mediated vasoconstriction and aldosterone release. ARBs are very well tolerated. 19
20 They do not affect bradykinin and, therefore, do not cause a dry cough like ACE inhibitors. Type I receptor are responsible for most unwanted cardiovascular effect of Ag II, so inhibition of this receptors have beneficial effect. So Ag II will bind with Ag type II receptors and produce benefit effects. Candesartan, irbesartan, and telmisartan have much stronger blockade than either losartan or valsartan. Most of these agents can be dosed once daily, except twice daily dosing may be needed when high doses of candesartan, eprosartan, or losartan are used. Similar to ACE inhibitors, initial doses may need to be lower in elderly patients and those who are taking a diuretic or are volume depleted. Monitoring requirements, contraindications, and side effects (other than cough) are similar for ARBs and ACE inhibitors. 20
Antihypertensive drugs SUMMARY Made by: Lama Shatat
Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone
More informationAntihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting
More information7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension
Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine
More informationCardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
More informationManagement of Hypertension
Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal
More informationAntihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment
Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit
More informationIntroductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs
Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys
More informationChapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories
Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes
More informationAntihypertensives. Diagnostic category
Measurement of blood pressure At first assessment, take both arms then choose the one with the higher reading. Beware of orthostatic hypotension. Measure BP in sitting position, and repeat after patient
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationHypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to
Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to 90 mmhg. These pressures are called Normal blood pressure
More informationDRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)
DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) Beta-blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension. Examples
More informationSection 3, Lecture 2
59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect
More informationHypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy
Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic
More informationBeta 1 Beta blockers A - Propranolol,
Pharma Lecture 3 Beta blockers that we are most interested in are the ones that target Beta 1 receptors. Beta blockers A - Propranolol, it s a non-selective competitive antagonist of beta 1 and beta 2
More informationSystemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept
Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Continents 1- introduction 2- classification/definition 3- classification/etiology 4-etiology in both categories 5- complications
More informationIntroduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP
Introduction Hypertension is a persistent elevation of blood pressure above 140 / 90 mmhg for more than three sitting. (0ptimal level
More informationHypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati
CHAPTER-I CARDIOVASCULAR SYSTEM Hypertension SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati Hypertension
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationNew classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100
Hypertension 1 Definition Hypertension can be defined as a condition where blood pressure is elevated to an extent that clinical benefit is obtained from blood pressure lowering. it is an important risk
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationApproach to patient with hypertension. Dr. Amitesh Aggarwal
Approach to patient with hypertension Dr. Amitesh Aggarwal Definition A systolic blood pressure ( SBP) >139 mmhg and/or A diastolic (DBP) >89 mmhg. Based on the average of two or more properly measured,
More informationAngina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.
Lonet Tablet Description Lonet contains Atenolol, a synthetic β1 selective (cardioselective) adrenoreceptor blocking agent without membrane stabilising or intrinsic sympathomimetic (partial agonist) activity.
More informationCategories of HTN. Overview of Hypertension. Types of Hypertension
Categories of HTN Overview of Hypertension Normal SBP 100 Quick review of the Basics: What is
More informationAntihypertensive drugs: I. Thiazide and other diuretics:
Clinical assessment of hypertensive patient: You have to take history regarding the presence of other risk factors for CAb like diabetes mellitus, smoking, etc. Take history whether the patient takes medications
More informationβ adrenergic blockade, a renal perspective Prof S O McLigeyo
β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant
More information1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias
1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should
More informationRESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University
RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive
More informationAntihypertensive Agents
Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,
More informationHYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL
HYPERTENSION IN CKD LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Normal Increased risk Damage GFR
More informationHYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg
Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between
More informationHypertension Part 1. Overview of Hypertension.
Hypertension Part 1 Overview of Hypertension http://silverchealth.com/wp-content/uploads/2012/01/hypertension1.gif Hypertension is sustained elevation of resting systolic BP ( 140 mm Hg), diastolic BP
More informationM2 TEACHING UNDERSTANDING PHARMACOLOGY
M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To
More informationsympatholytics sympatholytics sympatholytics
sympatholytics sympatholytics sympatholytics CNS-ACTING SYMPATHOPLEGICS Sympathetic brain signals Doesn t affect baroreceptor reflex (no orthostatic hypotension) Methyldopa α-methylne crosses BBB (+) α-adrenoreceptors
More informationHypertension Management - Summary
Who should have blood pressure assessed? Hypertension Management - Summary All patients over the age of 40 years, every 1-3 years in order to determine their cardiovascular risk (ie. Framingham Risk Score)
More informationManagement of Hypertension. Ahmed El Hawary MD Suez Canal University
Management of Hypertension Ahmed El Hawary MD Suez Canal University Minimal vs. Optimal Care Resources more than science affect type of care and level of management. what is possible (minimal care) and
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationCirculation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.
Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries
More information5.2 Key priorities for implementation
5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail
More informationHypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital
Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment
More informationHypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC
HypertensionTreatment Guidelines Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC Objectives: Review the definition of the different stages of HTN. Review the current guidelines for treatment of HTN. Provided
More informationHeart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationTowards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:
Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Cardiac Output (CO) CO=SVxHR (stroke volume x heart rate) Cardiac output: The amount of blood
More informationANTI- HYPERTENSIVE AGENTS
CLINICAL ANTI- HYPERTENSIVE AGENTS Jacqueline van Schoor, MPharm, BSc (Hons) Amayeza Info Centre Hypertension represents a major public health concern. It affects about a billion people worldwide and is
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More informationRole of Minerals in Hypertension
Role of Minerals in Hypertension Lecture objectives By the end of the lecture students will be able to Define primary and secondary hypertention and their risk factors. Relate role of minerals with hypertention.
More informationHeart Failure. Dr. Alia Shatanawi
Heart Failure Dr. Alia Shatanawi Left systolic dysfunction secondary to coronary artery disease is the most common cause, account to 70% of all cases. Heart Failure Heart is unable to pump sufficient blood
More informationHypertension Management Controversies in the Elderly Patient
Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No
More informationByvalson. (nebivolol, valsartan) New Product Slideshow
Byvalson (nebivolol, valsartan) New Product Slideshow Introduction Brand name: Byvalson Generic name: Nebivolol, valsartan Pharmacological class: Beta-blocker + angiotensin II receptor blocker (ARB) Strength
More informationLow Efficacy Diuretics. Potassium sparing diuretics. Carbonic anhydrase inhibitors. Osmotic diuretics. Miscellaneous
University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D Low Efficacy Diuretics 1. Potassium sparing diuretics 2. Carbonic anhydrase inhibitors 3. Osmotic diuretics 4. Miscellaneous
More informationTreatment of Essential Hypertension
2016 edition by Mark A. Simmons, PhD Department of Pharmaceutical Sciences School of Pharmacy University of Maryland Eastern Shore Originally developed by Hugh J. Burford, PhD, FCP Department of Pharmacology
More informationDiuretic Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Diuretic Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Potassium-sparing diuretics The Ion transport pathways across the luminal and basolateral
More informationPharmacologic Management of Hypertension
Current Concepts In Management of Fernando Vega, MD Secondary - Definition Renovascular Disease (The kidney doesn t get impressed by blood pressure) Renovascular stenosis Renal artery stenosis Fibromuscular
More informationChapter 10 Worksheet Blood Pressure and Antithrombotic Agents
Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances
More informationThe Failing Heart in Primary Care
The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and
More informationLXIV: DRUGS: 4. RAS BLOCKADE
LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations
More informationFrom the desk of the: THE VIRTUAL NEPHROLOGIST
Hypertension, also referred to as high blood pressure or HTN, is a medical condition in which the blood pressure is chronically elevated. It is a very common illness. One out of three American adults has
More informationPRINCIPLES OF DIURETIC ACTIONS:
DIURETIC: A drug that increases excretion of solutes Increased urine volume is secondary All clinically useful diuretics act by blocking Na + reabsorption Has the highest EC to IC ratio = always more sodium
More informationHeart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid
Failure? blood supply insufficient for body needs CHF = congestive heart failure increased blood volume, interstitial fluid Underlying causes/risk factors Ischemic heart disease (CAD) 70% hypertension
More informationPresentation of hypertensive emergency
Presentation of hypertensive emergency Definitions surrounding hypertensive emergency Hypertension: elevated blood pressure (BP), usually defined as BP >140/90; pathological both in isolation and in association
More informationDiversity and HTN: Approaches to optimal BP control in AfricanAmericans
Diversity and HTN: Approaches to optimal BP control in AfricanAmericans Quinn Capers, IV, MD, FACC, FSCAI Assistant Professor of Medicine Associate Dean for Admissions Do Racial Differences Really Exist
More informationUpdate in Hypertension
Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded
More informationUniversity of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D
University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D Cardiovascular Pharmacology 1. Antihypertensives 2. Antianginal 3. Drugs for HF 4. Antiarrythemics 5. Drugs for Hyperlipoproteniemia
More informationAdrenergic Receptor as part of ANS
Adrenergic Receptor as part of ANS Actions of Adrenoceptors Beta-1 adrenergic receptor Located on the myocytes of the heart Specific actions of the β1 receptor include: 0 Increase cardiac output, by 0
More informationHEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationHEART FAILURE SUMMARY. and is associated with significant morbidity and mortality. the cornerstone of heart failure treatment.
HEART FAILURE SUMMARY + Heart Failure is a condition affecting a large number of Irish people and is associated with significant morbidity and mortality. + ACE inhibitors, in combination with diuretics,
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationPharmacology of the Sympathetic Nervous System II
Pharmacology of the Sympathetic Nervous System II Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia
More informationTreatment of Essential Hypertension
2016 edition by Mark A. Simmons, PhD Department of Pharmaceutical Sciences School of Pharmacy University of Maryland Eastern Shore Originally developed by Hugh J. Burford, PhD, FCP Department of Pharmacology
More informationHypertensives Emergency and Urgency
Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More informationBlood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD
Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationHypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program
Hypertension: JNC-7 Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! Reference Card
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationMANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION
Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationDiuretics (Saluretics)
Diuretics (Saluretics) Diuretics increase urine excretion mainly by reabsorption of salts and water from kidney tubules These agents are ion transport inhibitors that decrease the reabsorption of Na+ at
More informationDRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI
DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI 3. Vasodilators Drugs which dilate blood vessels ( decrease peripheral vascular resistance) by acting on smooth muscle cells through non-autonomic mechanisms:
More informationPharmacology - Problem Drill 11: Vasoactive Agents
Pharmacology - Problem Drill 11: Vasoactive Agents Question No. 1 of 10 1. Vascular smooth muscle contraction is triggered by a rise in. Question #01 (A) Luminal calcium (B) Extracellular calcium (C) Intracellular
More informationDr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None
Dr Narender Goel MD (Internal Medicine and Nephrology) drnarendergoel@gmail.com Financial Disclosure: None, Conflict of Interest: None 12 th December 2013, New York Visit us at: http://kidneyscience.info/
More informationHypertension Epidemiology 6% of deaths worldwide Defined as any of the following: systolic blood pressure 140 mmhg, diastolic blood pressure 90 mmhg, taking antihypertensive medications Pulse pressure=
More information1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril.
SUMMARY 1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril. 2. While diuretics and beta-blockers remain first-line antihypertensive
More informationBy Prof. Khaled El-Rabat
What is The Optimum? By Prof. Khaled El-Rabat Professor of Cardiology - Benha Faculty of Medicine HT. Introduction Despite major worldwide efforts over recent decades directed at diagnosing and treating
More informationDr Doris M. W Kinuthia
Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of
More informationCOMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan
Rotazar (Film coated tablets) Irbesartan Rotazar 75 mg, 150 mg, 300 mg COMPOSITION A film coated tablet contains Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar 75 mg, 150 mg, 300 mg PHARMACOLOGICAL
More information신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure
신장환자의혈압조절 K/DOQI Clinical practice guidelines on Hypertension and Antihypertensive agents in CKD 나기영 Factors involved in the regulation of blood pressure Renal function curve MAP (mmhg) Central role of
More informationWhat is hypertension?
HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90
More informationStructure and organization of blood vessels
The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins
More informationPreventing and Treating High Blood Pressure
Preventing and Treating High Blood Pressure: Finding the Right Balance of Integrative and Pharmacologic Approaches Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Blood Pressure
More informationDIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE. Jules B. Puschett, M.D.
DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE Jules B. Puschett, M.D. Diuretic Resistance A clinical circumstance in which patients do not respond to a combination of salt restriction and even large
More informationAntihypertensive Agents
Antihypertensive Agents Öner Süzer www.onersuzer.com osuzer@istanbul.edu.tr Last update: 13.11.2009 1 Süzer Farmakoloji 3. Baskı 2005 2 1 Süzer Farmakoloji 3. Baskı 2005 3 Süzer Farmakoloji 3. Baskı 2005
More informationCombination Therapy for Hypertension
Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP
More informationEstimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches
Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder
More informationDr. Vishaal Bhat. anti-adrenergic drugs
Dr. Vishaal Bhat anti-adrenergic drugs Divisions of human nervous system Human Nervous system Central Nervous System Peripheral Nervous System Autonomic Nervous System Nervous system Includes neurons and
More informationWhat in the World is Functional Medicine?
What in the World is Functional Medicine? An Introduction to a Systems Based Approach of Chronic Disease Meneah R Haworth, FNP-C Disclosure v I am a student of the Institute for Functional Medicine. They
More informationAmlodipine plus Lisinopril Tablets AMLOPRES-L
Amlodipine plus Lisinopril Tablets AMLOPRES-L COMPOSITION AMLOPRES-L Each uncoated tablet contains: Amlodipine besylate equivalent to Amlodipine 5 mg and Lisinopril USP equivalent to Lisinopril (anhydrous)
More information